VTRS vs WST
Viatris vs West Pharmaceutical Services — AI-powered side-by-side comparison
VS
WST
West Pharmaceutical Services
71
Buy
| Metric | VTRS | WST |
|---|
| AI Score |
69
|
71
|
| Price |
$16.41
|
$353.62
|
| P/E Ratio |
-45.64×
|
44.99×
|
| ROE |
-23.9%
|
15.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
34.8%
|
36.8%
|
| Debt / Equity |
0.94×
|
0.10×
|
| Dividend Yield |
2.9%
|
0.2%
|
| RSI (14) |
31.0
|
61.3
|
| Beta |
0.902
|
1.159
|
| Expected Upside |
+0.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for VTRS versus WST.
WST leads by 2 points.
WST scores 71/100 (Buy) versus VTRS at 69/100 (Buy).
VTRS Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
WST Committee View
100% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical